[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 710500, "exercisedValue": 0, "unexercisedValue": 56986}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 416700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 54, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 34.59, "open": 33.85, "dayLow": 28.2401, "dayHigh": 33.85, "regularMarketPreviousClose": 34.59, "regularMarketOpen": 33.85, "regularMarketDayLow": 28.2401, "regularMarketDayHigh": 33.85, "payoutRatio": 0.0, "beta": 1.194, "forwardPE": -12.711865, "volume": 42373, "regularMarketVolume": 42373, "averageVolume": 51619, "averageVolume10days": 31060, "averageDailyVolume10Day": 31060, "bid": 28.19, "ask": 30.93, "bidSize": 1, "askSize": 1, "marketCap": 183377696, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 54.3, "fiftyDayAverage": 38.27, "twoHundredDayAverage": 18.083, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 186144464, "profitMargins": 0.0, "floatShares": 2994199, "sharesOutstanding": 6112590, "sharesShort": 50687, "sharesShortPriorMonth": 32525, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.3504, "heldPercentInstitutions": 0.4225, "shortRatio": 1.3, "shortPercentOfFloat": 0.0165, "impliedSharesOutstanding": 6102530, "bookValue": 1.403, "priceToBook": 21.382751, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -6474726, "trailingEps": -4.11, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 8.983361, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 30.0, "targetHighPrice": 76.0, "targetLowPrice": 40.08, "targetMeanPrice": 58.69333, "targetMedianPrice": 60.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 6020084, "totalCashPerShare": 1.141, "totalDebt": 0, "quickRatio": 5.361, "currentRatio": 5.405, "returnOnAssets": -0.59667, "returnOnEquity": -1.12038, "freeCashflow": -3873349, "operatingCashflow": -5951620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Monopar Therapeutics Inc.", "regularMarketChangePercent": -13.2697315, "regularMarketPrice": 30.0, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1743808350, "regularMarketTime": 1743796803, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1576765800000, "postMarketChangePercent": -0.0333341, "postMarketPrice": 29.99, "postMarketChange": -0.0100002, "regularMarketChange": -4.59, "regularMarketDayRange": "28.2401 - 33.85", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 51619, "fiftyTwoWeekLowChange": 28.28, "fiftyTwoWeekLowChangePercent": 16.44186, "fiftyTwoWeekRange": "1.72 - 54.3", "fiftyTwoWeekHighChange": -24.3, "fiftyTwoWeekHighChangePercent": -0.44751382, "fiftyTwoWeekChangePercent": 898.3361, "earningsTimestamp": 1743422401, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.11, "epsForward": -2.36, "epsCurrentYear": -2.63333, "priceEpsCurrentYear": -11.392419, "fiftyDayAverageChange": -8.27, "fiftyDayAverageChangePercent": -0.21609616, "twoHundredDayAverageChange": 11.917, "twoHundredDayAverageChangePercent": 0.6590167, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "shortName": "Monopar Therapeutics Inc.", "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]